AZA-b3-CYCLODIPEPTIDES
343
General cyclization procedure (step iv). Typically, a linear precursor
(1 mmol) Boc-aza-b3 Phe-aza-b3 Phe-OH 1c, or Boc-aza-b3 Phe-NMe-aza-
b3 Phe-OH 2c, or Boc-aza-b3 Phe-NMe-aza-b3 (a-Methyl-Phe)-OH 3c
was treated with a mixture of DCM/TFA (6 ml/4 ml) for 12 h. The excess
of TFA was then co-evaporated under reduced pressure with toluene
(3 ꢂ 20 ml) then ether (3 ꢂ 20 ml) until a white foam appeared. The crude
residue was dissolved in 20 ml of DCM and 10 mmol of triethylamine was
added. This solution was poured drop by drop into a solution of EDCI
(6 mmol) and HOBT (6 mmol) in 1.5 liters of DCM. The reaction was
stirred vigorously for 24 h. The volume was then reduced to around
100 ml. The addition of 20 ml of 1 N HCl under stirring gave rise to the ap-
pearance of a white solid (HOBT, HCl) which was filtrated by suction.
The solution was then washed successively with 20 ml of 1 N HCl, twice
with 20 ml of water, twice with 20 ml of 1 N NaHCO3, dried on Na2SO4,
and evaporated. For compound C1–C3 the crude reaction product was
obtained as a foam. Compounds C1–C3 were precipitated by addition of
diethyl ether to give a white solid which was filtered. Yield C1: (42%),
C2: (34%), C3: (28%). Monocrystals of C1 were obtained from a toluene/
ethanol mixture. Monocrystals of C2 and C3 were grown in toluene.
then 4.14 g of glyoxylic acid (45 mmol). After 0.5 h of stirring, the mixture
was acidified with a solution of 2 N HCl until pH ꢃ 1–2. The mixture was
stirred for 1 h at room temperature. The pH was adjusted to 9 using solid
NaHCO3. EtOH was removed in vacuo and the aqueous phase was
washed twice with 30 ml of DCM. The aqueous phase was acidified with
a solution of 1 N HCl, extracted twice with 30 ml of DCM. The organic
layers were dried over Na2SO4. Filtration and evaporation of the solvent
gave monomer Boc-NMe-aza-b3 Phe-OH 2 (6.4 g, 73%) as a colorless oil.
1H NMR (200 MHz, CDCl3) d (ppm): 1.39 (s, 9H, 3xCH3), 2.98 (s, 3H,
CH3), 3.60 (s, 2H, CH2), 4.10 (s, 2H, CH2), 7.31–7.39 (m, 5H, C6H5).
Synthesis and characterization of H-NMe-aza-b3 Phe-OMe
2a. Thionyl chloride (2.50 g, 21mmol) was added dropwise to a solution
of monomer Boc-NMe-aza-b3 Phe-OH 2 (3.08g, 10.48mmol) in MeOH
(20 ml). The mixture was stirred for 12h at room temperature. MeOH was
evaporated; triturating the residue in diethyl ether, followed by filtration,
gave the chlorhydrate HCl, HNMe-aza-b3 Phe-OMe quantitatively. 1H
NMR (200MHz, CDCl3) d (ppm): 3.01 (s, 3H, CH3), 3.81 (s, 3H, CH3),
3.94 (s, 2H, CH2), 4.47 (s, 2H, CH2), 7.39 (s, 5H, C6H5). The chlorhydrate
was dissolved in 10ml of water, 20ml of DCM were added, and the
pH of the aqueous phase was then adjusted to 8–9 using 1 N NaHCO3.
The organic layer was dried over Na2SO4 and DCM was evaporated to
give H-NMe-aza-b3 Phe-OMe 2a (2.3 g, 90%) as a clear oil which was
engaged immediately in the next step without further purification. 1H
NMR (200MHz, CDCl3) d (ppm): 2.99 (s, 3H, CH3), 3.79 (s, 3H, CH3),
3.93 (s, 2H, CH2), 4.45 (s, 2H, CH2), 7.38 (s, 5H, C6H5) 11.25 (broad,
2H, NH, HCl).
Synthesis and characterization of compound C1. Compound Boc-
aza-b3 Phe-OH 1 was obtained as described in our previous work.25 Pre-
cursors H-aza-b3 Phe-aza-b3 Phe-OMe 1a, Boc-(aza-b3 Phe)2-OMe 1b,
and Boc-(aza-b3 Phe)2-OH 1c were obtained following general procedure,
respectively: Inversion/protection (step i), coupling procedure (step ii), and
saponification (step iii). They were roughly purified and used as such.
Compound C1 was obtained following general cyclization procedure (step
iv). Yield: 42%. Mp = 236 ꢁC. Crystals of C1 were grown from a toluene/
ethanol mixture. 1H NMR (500 MHz, CDCl3 10–2 M, 298 K) d (ppm):
3.45 (broad, 2H, NCH2CO), 3.92 (broad, 6H, NCH2CO and 2CH2Ph),
7.29 (broad, 2H, NH), 7.37–7.34 (m, 10H, aromatics). 13C NMR
(75 MHz, CDCl3) d (ppm): 62.3 (CH2), 62.5 (CH2), 128 (CH), 128.6
(CH), 129 (CH), 135.7 (C), 171.6 (CO). HRMS (ESI) Calcd for
C18H20N4O2Na 347.1484; Found, 347.1487.
Synthesis and characterization of Boc-aza-b3 Phe-NMe-aza-b3
Phe-OH 2c. Monomer H-NMe-aza-b3 Phe-OMe 2a (1.14g, 5.5 mmol)
was coupled with monomer Boc-aza-b3 Phe-OH 1 following general
coupling procedure ii to give dimer Boc-aza-b3 Phe-NMe-aza-b3 Phe-OMe
2b quantitatively as a yellow oil. Compound 2b was saponified into
Boc-aza-b3 Phe-NMe-aza-b3 Phe-OH 2c (white foam, 96% for the two steps)
following general procedure iii. 1H NMR (200 MHz, CDCl3) d (ppm): 1.32
(s, 9H, 3xCH3), 3.03 (s, 3H, CH3), 3.53–4.16 (m, 8H, 4xCH2), 6.44 (broad,
1H, OH), 7.01 (s, 1H, NH), 7.28–7.37 (m, 10H, 2xC6H5).
Synthesis and characterization of compound C2. All precursors of
C2 were roughly purified and used as such.
Synthesis and characterization of Boc-NMe-NH2. To a cooled solu-
tion (0 ꢁC) of methylhydrazine (3.45 g, 75 mmol) in DCM (80 ml) was
added dropwise a solution of di-tert-butyldicarbonate (16.35 g, 75 mmol)
in 80 ml of DCM. The mixture was stirred at room temperature for 3 h.
The solvent was evaporated to afford quantitatively compound Boc-
NMe-NH2 as an oil. 1H NMR (200 MHz, CDCl3) d (ppm): 1.48 (s, 9H,
3xCH3), 3.07 (s, 3H, CH3), 4.13 (broad, 2H, NH2).
Synthesis of compound C2. Compound C2 was obtained following
general cyclization procedure (step iv). Yield: 34%. Mp = 162 ꢁC. Crystals
of C2 were obtained in toluene. 1H NMR (500 MHz, CDCl3/10–2 M/
298 K) d (ppm): 3.02 (s, 3H, CH3), 3.42 (d, J = 13.5Hz, 1H, CHB1), 3.53
(d, J = 13.8Hz, 1H, CHB2), 3.90 (d, J = 13.8Hz, 1H, CHA2), 3.92
(d, J = 12.9Hz, 1H, CHB3), 3.93 (s, 2H, CH2), 4.04 (d, J = 13.5Hz, 1H,
CHA1), 4.07 (d, J= 12.9Hz, 1H, CHA3), 6.54 (s, 1H, NH), 7.31–7.38 (m, 10H,
CHar). 13C NMR (75MHz, CDCl3/10–2 M/298 K) d (ppm): 25.64 (CH3),
58.36 (CH2), 58.64 (CH2), 62.11 (CH2), 64.02 (CH2), 128.04 (CHp), 128.08
(CHp), 128.62 (CH), 128.65 (CH), 128.92 (CH), 129.20 (CH), 135.62 (C),
135.80 (C), 170.75 (CO), 170.77 (CO). HRMS (ESI) Calcd for
Synthesis and characterization of Boc-NMe-N=CHPh. Benzalde-
hyde (7.95 g, 75 mmol) was added slowly to a solution of Boc-NMe-NH2
(10.95 g, 75 mmol) in diethyl ether (100 ml) The mixture was stirred for
12 h at room temperature. The solution was dried with Na2SO4, then fil-
tered. Evaporation of the solvent afforded quantitatively hydrazone Boc-
NMe-N=CHPh as an oil. 1H NMR (200 MHz, CDCl3) d (ppm): 1.56 (s,
9H, 3xCH3), 3.10 (s, 3H, CH3), 7.35–7.43 (m, 3H, 3xCH), 7.70–7.77 (m,
2H, 2xCH), 7.85 (s, 1H, CH).
C19H22N4O2Na 361.16405; Found, 361.1640.
Synthesis and characterization of compound C3. All precursors of
C3 were roughly purified and used as such.
Synthesis and characterization of hydrazone Boc-NMe-N=C(Me)
Synthesis and characterization of hydrazine Boc-NMe-NHBn. To
a stirred solution of hydrazone Boc-NMe-N=CHPh (17.55g, 75mmol) in
120ml EtOH were added 5.20 g (82.75 mmol) of sodium cyanoborohydrure.
After 30 min of stirring, the mixture was acidified with a solution of
2 N HCl to pH ꢃ 1–2. Then, the pH was adjusted to 9 using solid
NaHCO3. EtOH was removed in vacuo and the aqueous phase was
extracted twice with DCM. The combined organic layers were
dried over Na2SO4. Filtration and evaporation of the solvent give
Boc-NMe-NHBn as an oil (15.5 g, 88%). 1H NMR (200 MHz, CDCl3)
d (ppm): 1.48 (s, 9H, 3xCH3), 3.02 (s, 3H, CH3), 4.10 (s, 2H, CH2),
7.31–7.40 (m, 5H, C6H5).
Ph. To
a
solution of Boc-NMe-NH2 (15.87 g, 0.11 mol) and
acetophenone (13 g, 0.11 mol) in 150 ml of diethyl ether were added two
drops of acetic acid. After stirring for 12 h, the mixture was dried over
Na2SO4, filtrated, and evaporated to give hydrazone BocNMe-N=C(Me)
Ph (26.96 g) quantitatively as an oil. NMR 1H (300 MHz, CDCl3/298 K)
d (ppm): 1.48 (s, 9H, 3xCH3), 2.29 (s, 3H, CH3), 3.23 (s, 3H, CH3),
7.17–7.85 (m, 5H, CHar).
Synthesis and characterization of hydrazine Boc-NMe-NH(CH(Me)
Phe). To a solution of hydrazone Boc-NMe-N=C(Me)Ph (26.96 g,
0.11 mol) in 100 ml of EtOH were added 7.51 g (0.12 mol) of sodium
cyanoborohydrure. The mixture was stirred for 2 h after having adjusted
the solution to pH 5–6 using 2 N HCl. The mixture was acidified to pH 1
using 2 N HCl and stirred for 15 min. Then, NaHCO3 (powder) was added
to adjust the solution to pH 9. EtOH was removed in vacuo and the
Synthesis and characterization of Boc-NMe-aza-b3 Phe-OH 2. To a
solution of hydrazine Boc-NMe-NHBn (7.08 g, 30 mmol) in EtOH (50 ml)
were added successively 2.83 g of sodium cyanoborohydride (45 mmol),
Chirality DOI 10.1002/chir